Well, we were told to look at RSH by @Yenom23 so I did and found some questions that I couldn't find the answer to so I asked here and still haven't received a respond, in particular to whether Wheezo receive regulatory approval for clinical data only tested against the stethoscope and whether it was Mark I or II?
Respiri investor Presentation, page-35
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.25M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 165814 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 189727 | 2 |
View Market Depth
| Last trade - 16.12pm 30/08/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable